Genetic polymorphisms and sepsis in premature neonates

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Esposito, Susanna ^a   Zampiero, Alberto ^a   Pugni, Lorenza ^a   Tabano, Silvia ^a   Pelucchi, Claudio ^b   Ghirardi, Beatrice ^a   Terranova, Leonardo ^a   Miozzo, Monica ^a   Mosca, Fabio ^a   Principi, Nicola ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERICIDAL PERMEABILITY INCREASING PROTEIN; BETA DEFENSIN 1; CD14 ANTIGEN; INTERLEUKIN 1BETA; INTERLEUKIN 8; MATRIX METALLOPROTEINASE 16;

ARTICLE; BPI GENE; CD14 GENE; CONTROLLED STUDY; DEFBETA1 GENE; DISEASE SEVERITY; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GRAM NEGATIVE INFECTION; HUMAN; IL1BETA GENE; IL8 GENE; LTA GENE; MAJOR CLINICAL STUDY; MALE; MMP 16 GENE; NEWBORN; NEWBORN SEPSIS; NONHUMAN; PREMATURITY; RETROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; GENETICS; MICROBIOLOGY; SEPSIS;

FEMALE; GENOTYPE; HUMANS; INFANT, NEWBORN; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PREMATURE BIRTH; RETROSPECTIVE STUDIES; SEPSIS;

EID: 84904396536     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101248     Document Type: Article

References (46)

1. Mehta K, Bhatta NK, Majhi S, Shrivastava MK, Singh RR (2013) Oral zinc supplementation for reducing mortality in probable neonatal sepsis: a double blind randomized placebo controlled trial. Indian Pediatr 50: 390-393.
2. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, et al. (2002) Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 110: 285-291. (Pubitemid 34833012)
3. López Sastre JB, Coto Cotallo D, Fernández Colomer B (2002) Neonatal sepsis of nosocomial origin: an epidemiological study from the "Grupo de Hospitales Castrillo." J Perinat Med 30: 149-157.
4. Namath A, Patterson AJ (2009) Genetic polymorphisms in sepsis. Crit Care Clin 25: 835-856.
5. Wong HR (2012) Genetics and genomics in pediatric septic shock. Crit Care Med 40: 1618-1626.
6. Jabandziev P, Smerek M, Michalek J Sr, Fedora M, Kosinova L, et al. (2014) Multiple gene-to-gene interactions in children with sepsis: a combination of five gene variants predicts outcome of life-threatening sepsis. Crit Care 18: R1.
7. Chung LP, Waterer GW (2011) Genetic predisposition to respiratory infection and sepsis. Crit Rev Clin Lab Sci 48: 250-268.
8. Abu-Maziad A, Schaa K, Bell EF, Dagle JM, Cooper M, et al. (2010) Role of polymorphic variants as genetic modulators of infection in neonatal sepsis. Pediatr Res 68: 323-329.
9. Weitkamp JH, Stüber F, Bartmann P (2000) Pilot study assessing TNF gene polymorphism as a prognostic marker for disease progression in neonates with sepsis. Infection 28: 92-96. (Pubitemid 30189614)
10. Chauhan M, McGuire W (2008) Interleukin-6 (-174C) polymorphism and the risk of sepsis in very low birth weight infants: meta-analysis. Arch Dis Child Fetal Neonatal Ed 93: F427-F429.
11. Levy O, Martin S, Eichenwald E, Ganz T, Valore E, et al. (1999) Impaired innate immunity in the newborn: newborn neutrophils are deficient in bactericidal/permeability-increasing protein. Pediatrics 104: 1327-1333.
12. Levy O (2005) Innate immunity of the human newborn: distinct cytokine responses to LPS and other Toll like receptor agonists. J Endotoxin Res 11: 113-116.
13. Vermont Oxford Network Database Mannual of Operations, Release 2.0. Burlington, VT: Vermont Oxford Network; 1993.
14. Chirico G, Barbieri F, Chirico C (2009) Antibiotics for the newborn. J Matern Fetal Neonatal Med 22 Suppl 3: 46-49.
15. European Medicines Agency. Report on the Expert Meeting on Neonatal and Paediatric Sepsis. 8 June 2010, EMA London. Available at http://www.ema.europa. eu/docs/en-GB/document-library/Report/2010/12/WC500100199.pdf. Accessed on 15 January 2014.
16. Goldstein B, Giroir B, Randolph A (2005) International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 6: 2-8.
17. Casabonne D, Reina O, Benavente Y, Becker N, Maynadié M, et al. (2011) Single nucleotide polymorphisms of matrix metalloproteinase 9 (MMP9) and tumor protein 73 (TP73) interact with Epstein-Barr virus in chronic lymphocytic leukemia: results from the European case-control study EpiLymph. Haematologica 96: 323-327.
18. Morales-García G, Falfán-Valencia R, García- Ramírez RA, Camarena Á, Ramirez-Venegas A, et al. (2012) Pandemic influenza A/H1N1 virus infection and TNF, LTA, IL1B, IL6, IL8, and CCL polymorphisms in Mexican population: a case-control study. BMC Infect Dis 12: 299.
19. Wilson N, Driss A, Solomon W, Dickinson-Copeland C, Salifu H, et al. (2013) CXCL10 gene promoter polymorphism -1447A.G correlates with plasma CXCL10 levels and is associated with male susceptibility to cerebral malaria. PLoS One 8: e81329.
20. Bochud PY, Bochud M, Telenti A, Calandra T (2007) Innate immunogenetics: a tool for exploring new frontiers of host defence. Lancet Infect Dis 7: 531-542. (Pubitemid 47077714)
21. Ma P, Chen D, Pan J, Du B (2002) Genomic polymorphism within interleukin-1 family cytokines influences the outcome of septic patients. Crit Care Med 30: 1046-1050. (Pubitemid 34508027)
22. Read RC, Cannings C, Naylor SC, Timms JM, Maheswaran R, et al. (2003) Variation within genes encoding interleukin-1 and the interleukin-1 receptor antagonist influence the severity of meningococcal disease. Ann Intern Med 138: 534-541.
23. Bellamy, Ruwende C, Corrah T, McAdam KP, Whittle HC, et al. (1998) Assessment of the interleukin 1 gene cluster and other candidate gene polymorphisms in host susceptibility to tuberculosis. Tuber Lung Dis 79: 83-89.
24. Fang XM, Schroder S, Hoeft A, Stuber F (1999) Comparison of two polymorphisms of the interleukin-1 gene family: interleukin-1 receptor antagonist polymorphism contributes to susceptibility to severe sepsis. Crit Care Med 27: 1330-1334. (Pubitemid 29379372)
25. Dinarello CA, Wolff SM (1993) The role of interleukin-1 in disease. N Engl J Med 328: 106-116.
26. Elkington PT, O'Kane CM, Friedland JS (2005) The paradox of matrix metalloproteinases in infectious disease. Clin Exp Immunol 142: 12-20. (Pubitemid 41361000)
27. Khokha R, Murthy A, Weiss A (2013) Metalloproteinases and their natural inhibitors in inflammation and immunity. Nat Rev Immunol 13: 649-665.
28. Chen Q, Jin Y, Fang X (2009) Genomic variations within matrix metallopro-tease-9 and severe sepsis. Crit Care 13 (Suppl. 1): 354.
29. Prasad AS (2007) Zinc: Mechanisms of host defense. J Nutr 137: 1345-1349.
30. Cvijanovich N, Shanley TP, Lin R, Allen GL, Thomas NJ, et al. (2008) Validating the genomic signature of pediatric septic shock. Physiol Genomics 34: 127-134.
31. Shanley TP, Cvijanovich N, Lin R, Allen GL, Thomas NJ, et al. (2007) Genome-level longitudinal expression of signaling pathways and gene networks in pediatric septic shock. Mol Med 13: 495-508. (Pubitemid 47585744)
32. Wong HR, Cvijanovich N, Allen GL, Lin R, Anas N, et al. (2009) Genomic expression profiling across the pediatric systemic inflammatory response syndrome, sepsis, and septic shock spectrum. Crit Care Med 37: 1558-1566.
33. Wong HR, Freishtat RJ, Monaco M, Odoms K, Shanley TP (2010) Leukocyte subset-derived genomewide expression profiles in pediatric septic shock. Pediatr Crit Care Med 11: 349-355.
34. Wong HR, Shanley TP, Sakthivel B, Cvijanovich N, Lin R, et al. (2007) Genome-level expression profiles in pediatric septic shock indicate a role for altered zinc homeostasis in poor outcome. Physiol Genonics 30: 146-155. (Pubitemid 47173278)
35. Hadchouel A, Decobert F, Franco-Montoya ML, Halphen I, Jarreau PH, et al. (2008) Matrix metalloproteinase gene polymorphisms and bronchopulmonary dysplasia: identification of MMP16 as a new player in lung development. PLoS One 3: e3188.
36. Nupponen I, Turunen R, Nevalainen T, Peuravuori H, Pohjavuori M, et al. (2002) Extracellular release of bactericidal/permeability-increasing protein in newborn infants. Pediatr Res 51: 670-674. (Pubitemid 34547327)
37. Michalek J, Svetlikova P, Fedora M, Klimovic M, Klapacova L, et al. (2007) Bactericidal permeability increasing protein gene variants in children with sepsis. Intensive Care Med 33: 2158-2164. (Pubitemid 350164567)
38. Shu Q, Shi Z, Zhao ZY, Chen Z, Yao HP, et al. (2006) Protection against pseudomonas aeruginosa pneumonia and sepsis-induced lung injury by overexpression of b-defensin 2 in rats. Shock 26: 365-371. (Pubitemid 44402021)
39. Chen QX, Lv C, Huang LX, Cheng BL, Xie GH, et al. (2007)) Genomic variations within DEFB1 are associated with the susceptibility to and the fatal outcome of severe sepsis in Chinese Han population. Genes Immun 8: 439-443. (Pubitemid 47163106)
40. Ranoa DR, Kelley SL, Tapping RI (2013) Human lipopolysaccharide-binding protein (LBP) and CD14 independently deliver triacylated lipoproteins to Tolllike receptor 1 (TLR1) and TLR2 and enhance formation of the ternary signaling complex. J Biol Chem 288: 9729-9741.
41. Zhang AQ, Yue CL, Gu W, Du J, Wang HY, et al. (2013) Association between CD14 promoter -159C/T polymorphism and the risk of sepsis and mortality: a systematic review and meta-analysis. PLoS One 8: e71237.
42. Noah TL, Henderson FW, Wortman IA, Devlin RB, Handy J, et al. (1985) Nasal cytokine production in viral acute upper respiratory infection of childhood. J Infect Dis 171: 584-592.
43. Hull J, Thomson A, Kwiatkowski D (2000) Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families. Thorax 55: 1023-1027.
44. Watanabe E, Buchman TG, Hirasawa H, Zehnbauer BA (2010) Association between lymphotoxin-alpha (tumor necrosis factor-beta) intron polymorphism and predisposition to severe sepsis is modified by gender and age. Crit Care Med 38: 181-193.
45. Woessner JF Jr (1999) Matrix metalloproteinase inhibition. From the Jurassic to the third millennium. Ann N Y Acad Sci 878: 388-403.
46. Komaroff E, Golub LM (2004) Subantimicrobial dose doxycycline efficacy as a matrix metalloproteinase inhibitor in chronic periodontitis patients is enhanced when combined with a non-steroidal anti-inflammatory drug. J Periodontol 75: 453-463. (Pubitemid 38461128)